Anhui Provincial Hospital

This trial tests whether adding daily oral zinc to standard targeted therapy and immunotherapy helps people with advanced liver cancer. About 60 participants will be randomly assigned to receive the standard treatment alone or with either 20 mg or 30 mg of zinc each day. The main…

This trial tests whether the time at which stem cells are infused after a transplant affects the risk of acute graft-versus-host disease (aGVHD), a serious complication where donor cells attack the patient's body. It involves 198 patients with nonmalignant blood diseases receivin…

This trial tests a drug called romiplostim N01 in people with leukemia who develop dangerously low platelet counts from their cancer treatment. The goal is to see if weekly injections can safely raise platelet levels and reduce the need for transfusions. The study involves about …

This study tests whether a drug called polyene phosphatidylcholine, given before and after surgery, can protect the liver in people with liver cancer. About 96 participants will receive either the drug combo or standard care. The goal is to see if it reduces liver injury after la…

This study tests a new treatment made from special stem cells (iMSC) for people with a serious complication after bone marrow transplant called graft-versus-host disease that does not respond to steroids. The treatment aims to control the disease by calming the immune system. Abo…

This early study tests a gene therapy called LCAR02 in up to 18 people with B-cell lymphoma that has relapsed or not responded to standard treatments. The therapy uses a modified gene to target and attack cancer cells. The main goals are to check safety and see if the treatment s…

This phase 3 trial is testing whether changing the timing of stem cell infusion after a single umbilical cord blood transplant can lower the risk of severe acute graft-versus-host disease (aGVHD) in people with blood cancers. The study will enroll 134 participants who are in remi…

This study looks at how long kidney transplant patients should take a common antibiotic (TMP-SMX) to prevent a serious lung infection called PJP. About 450 participants will be randomly assigned to different treatment durations. The goal is to find the safest and most effective l…

This study tests whether infusions of cells from umbilical cord blood can help people with mild to moderate Alzheimer's disease. Thirty participants will receive either a low dose, high dose, or a placebo (salt water) through an IV once a week for four weeks, plus a fifth dose a …

This phase 2 trial is testing whether a drug called ivonescimab, given together with a short course of targeted radiation, can help people with advanced esophageal cancer that has worsened after first treatment. The study will enroll 37 adults and track how long they live without…

This early-phase trial is testing a new therapy called Meta10-TIL for people with advanced solid tumors that have not responded to at least one prior treatment. The therapy uses a patient's own tumor-fighting immune cells, which are modified in the lab to work better, and then gi…

Researchers are building a computer model that combines detailed features from preoperative MRI scans with routine clinical information to estimate the risk of cancer returning after surgery for colorectal liver metastases. The study includes adults who had surgery for these live…

This study looks at whether measuring the liver's functional and total volume before treatment can help predict how well patients with advanced liver cancer respond to immunotherapy. Researchers will review imaging and clinical data from 467 patients who received immunotherapy fo…

This study follows 100 adults with blood disorders who receive an unrelated cord blood transplant. Researchers will measure levels of γδ T cells—a type of immune cell—in the blood at several time points over the first year. The goal is to see if the pattern of γδ T cell recovery …

This study is creating a large database of 2000 people whose cancer has spread to the liver. Researchers will collect information on patients' health, treatments, and outcomes to learn more about the disease and improve future care. No new treatments are being tested; the goal is…